• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种近乎普遍的基于住院治疗的预防方案对美国每年静脉血栓栓塞事件数量的影响。

Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US.

作者信息

Heit John A, Crusan Daniel J, Ashrani Aneel A, Petterson Tanya M, Bailey Kent R

机构信息

Department of Cardiovascular Diseases.

Division of Hematology, Department of Internal Medicine.

出版信息

Blood. 2017 Jul 13;130(2):109-114. doi: 10.1182/blood-2016-12-758995. Epub 2017 May 8.

DOI:10.1182/blood-2016-12-758995
PMID:28483763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5510788/
Abstract

The annual number of US venous thromboembolism (VTE) events, the number of potentially preventable events, and the effect of hospitalization-based prophylaxis are uncertain. We estimated VTE attack (incident plus recurrent VTE) rates and the total annual number of US VTE events related and unrelated to hospitalization using Rochester Epidemiology Project resources to identify all Olmsted County, Minnesota, residents with incident or recurrent VTE over the 6-year period 2005-2010. The average annual VTE attack rates related and unrelated to hospitalization were 282 and 8 per 10 000 person-years, respectively. The estimated average number of US VTE events was 495 669 per year (48% unrelated to hospitalization). Among Olmsted County residents hospitalized at a Mayo Clinic hospital from 2005 to 2010, the proportion of patients receiving VTE prophylaxis or with an indication that prophylaxis was unnecessary increased from ∼40% in 2005 to ∼90% by 2010. The annual age- and sex-adjusted hospitalization-related (in-hospital) VTE attack rates from 2005 to 2010 ranged from 251 to 306 (1155 to 1751) per 10 000 person-years (bed-years) and did not change significantly. The median durations of hospitalization and in-hospital prophylaxis were 3 days and 70 hours, respectively. A total of 75% of VTE events occurred after hospital discharge, with a 19.5-day median time to VTE. Additional efforts are needed to identify the individual inpatient and outpatient at high risk for incident and recurrent VTE and target (longer duration) primary and secondary prophylaxis to high-risk individuals who would benefit most.

摘要

美国每年静脉血栓栓塞(VTE)事件的数量、潜在可预防事件的数量以及基于住院治疗的预防措施的效果尚不确定。我们利用罗切斯特流行病学项目的资源,估算了2005年至2010年这6年期间美国与住院相关和不相关的VTE发作(新发加复发VTE)率以及VTE事件的年度总数,以确定明尼苏达州奥尔姆斯特德县所有新发或复发VTE的居民。与住院相关和不相关的VTE年平均发作率分别为每10000人年282例和8例。美国VTE事件的估计年平均数量为每年495669例(48%与住院无关)。在2005年至2010年于梅奥诊所医院住院的奥尔姆斯特德县居民中,接受VTE预防或有证据表明无需预防的患者比例从2005年的约40%增至2010年的约90%。2005年至2010年年龄和性别调整后的年度住院相关(院内)VTE发作率为每10000人年(床年)251至306例(1155至1751例),且无显著变化。住院和院内预防的中位持续时间分别为3天和70小时。总共75%的VTE事件发生在出院后,VTE的中位时间为19.5天。需要做出更多努力来识别发生新发和复发VTE的高危住院患者和门诊患者,并针对最能从中受益的高危个体进行(更长疗程的)一级和二级预防。

相似文献

1
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US.一种近乎普遍的基于住院治疗的预防方案对美国每年静脉血栓栓塞事件数量的影响。
Blood. 2017 Jul 13;130(2):109-114. doi: 10.1182/blood-2016-12-758995. Epub 2017 May 8.
2
Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.医院在药物预防静脉血栓栓塞症方面的表现和静脉血栓栓塞症的发生率:一项队列研究。
JAMA Intern Med. 2014 Oct;174(10):1577-84. doi: 10.1001/jamainternmed.2014.3384.
3
Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes.当地养老院奥姆斯特德县居民的静脉血栓栓塞症(VTE)发生率和与 VTE 相关的生存率。
Thromb Haemost. 2018 Jul;118(7):1316-1328. doi: 10.1055/s-0038-1660436. Epub 2018 Jul 2.
4
Reasons for the persistent incidence of venous thromboembolism.静脉血栓栓塞持续发生的原因。
Thromb Haemost. 2017 Jan 26;117(2):390-400. doi: 10.1160/TH16-07-0509. Epub 2016 Dec 15.
5
Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.美国住院急性病患者住院和门诊连续护理中的静脉血栓栓塞预防和风险:一项回顾性分析。
Adv Ther. 2019 Jan;36(1):59-71. doi: 10.1007/s12325-018-0846-2. Epub 2018 Dec 12.
6
Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study.择期膝关节镜手术后静脉血栓栓塞症的发生率:一项历史性队列研究。
J Thromb Haemost. 2013 Jul;11(7):1279-86. doi: 10.1111/jth.12283.
7
Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study.减重手术后静脉血栓栓塞症的发生率:一项基于人群的队列研究。
Obes Surg. 2013 Nov;23(11):1874-9. doi: 10.1007/s11695-013-1073-1.
8
Venous Thromboembolism Incidence After Craniofacial Surgery.颅面外科手术后静脉血栓栓塞的发生率
Ann Plast Surg. 2018 May;80(5):561-564. doi: 10.1097/SAP.0000000000001353.
9
Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patients.对美国真实患者在接受大型骨科或腹部手术后住院期间及出院后静脉血栓栓塞风险时间段的回顾性管理数据库研究。
Hosp Pract (1995). 2011 Apr;39(2):7-17. doi: 10.3810/hp.2011.04.390.
10
Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.对于因非手术指征住院的妇科恶性肿瘤患者,改善静脉血栓栓塞症药物预防的依从性并未降低静脉血栓栓塞症的发生率。
Int J Gynecol Cancer. 2015 Jan;25(1):152-9. doi: 10.1097/IGC.0000000000000312.

引用本文的文献

1
Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial.智能技术辅助的以患者为中心的静脉血栓栓塞管理(SmaVTE研究):一项随机对照试验的方案
JMIR Res Protoc. 2025 Jun 5;14:e67254. doi: 10.2196/67254.
2
Nurses' knowledge, attitudes, and practices regarding deep vein thrombosis and the nursing management.护士关于深静脉血栓形成及护理管理的知识、态度和实践。
Sci Rep. 2025 May 17;15(1):17174. doi: 10.1038/s41598-025-96551-0.
3
Audit of VTE prophylaxis prescribing preferences among orthopaedic consultants in Irish orthopaedic trauma centres.爱尔兰骨科创伤中心骨科顾问医生对静脉血栓栓塞症预防用药偏好的审计
Ir J Med Sci. 2025 Apr;194(2):575-582. doi: 10.1007/s11845-025-03909-4. Epub 2025 Feb 21.
4
Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.子宫切除术后延长静脉血栓栓塞预防措施中的种族差异。
PLoS One. 2025 Jan 28;20(1):e0318433. doi: 10.1371/journal.pone.0318433. eCollection 2025.
5
Inpatient pharmacological thromboprophylaxis in the antepartum period: an argument for risk-based thromboprophylaxis.孕期住院患者的药物性血栓预防:基于风险的血栓预防的依据
Am J Obstet Gynecol MFM. 2025 Mar;7(1S):101567. doi: 10.1016/j.ajogmf.2024.101567. Epub 2024 Nov 24.
6
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism.一项整群随机、II 型混合实施效果试验的方法,以前瞻性评估出院的高危内科患者延长疗程的血栓预防措施,以预防医院相关静脉血栓栓塞症。
Res Pract Thromb Haemost. 2024 Aug 21;8(6):102549. doi: 10.1016/j.rpth.2024.102549. eCollection 2024 Aug.
7
Impact of Clinical Decision Support with Mandatory versus Voluntary Venous Thromboembolism Risk Assessment in Hospitalized Patients.住院患者中强制性与自愿性静脉血栓栓塞风险评估的临床决策支持影响
TH Open. 2024 Sep 12;8(3):e317-e328. doi: 10.1055/s-0044-1790519. eCollection 2024 Jul.
8
What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold.什么构成静脉血栓栓塞的高风险?比较确定适当阈值的方法。
medRxiv. 2024 Sep 1:2024.08.30.24312871. doi: 10.1101/2024.08.30.24312871.
9
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).SEOM 临床指南:静脉血栓栓塞症(VTE)和癌症(2023 年)。
Clin Transl Oncol. 2024 Nov;26(11):2877-2901. doi: 10.1007/s12094-024-03605-2. Epub 2024 Aug 7.
10
Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices.住院成年患者的静脉血栓栓塞预防:美国医疗保健提供者对态度和实践的调查。
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102168. doi: 10.1016/j.rpth.2023.102168. eCollection 2023 Aug.

本文引用的文献

1
Reasons for the persistent incidence of venous thromboembolism.静脉血栓栓塞持续发生的原因。
Thromb Haemost. 2017 Jan 26;117(2):390-400. doi: 10.1160/TH16-07-0509. Epub 2016 Dec 15.
2
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.急性病医学患者贝曲西班的延长血栓预防。
N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.
3
Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.医院在药物预防静脉血栓栓塞症方面的表现和静脉血栓栓塞症的发生率:一项队列研究。
JAMA Intern Med. 2014 Oct;174(10):1577-84. doi: 10.1001/jamainternmed.2014.3384.
4
Stroke incidence and mortality trends in US communities, 1987 to 2011.美国社区 1987 至 2011 年的中风发病率和死亡率趋势。
JAMA. 2014 Jul 16;312(3):259-68. doi: 10.1001/jama.2014.7692.
5
Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).静脉血栓栓塞症发生率的长期变化趋势:伍斯特静脉血栓栓塞症研究(1985-2009)。
Am J Med. 2014 Sep;127(9):829-39.e5. doi: 10.1016/j.amjmed.2014.03.041. Epub 2014 May 6.
6
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.癌症活跃期患者静脉血栓栓塞复发和出血的预测因素:一项基于人群的队列研究。
Blood. 2014 Jun 19;123(25):3972-8. doi: 10.1182/blood-2014-01-549733. Epub 2014 Apr 29.
7
No association between hospital-reported perioperative venous thromboembolism prophylaxis and outcome rates in publicly reported data.在公开报告的数据中,医院报告的围手术期静脉血栓栓塞预防措施与结局发生率之间无关联。
JAMA Surg. 2014 Apr;149(4):400-1. doi: 10.1001/jamasurg.2013.4935.
8
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.利伐沙班用于急性病医学患者的血栓预防。
N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.
9
Venous thromboembolism in adult hospitalizations - United States, 2007-2009.成人住院患者静脉血栓栓塞症 - 美国,2007-2009 年。
MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4.
10
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.流行病学研究结果和公共卫生决策的可推广性:罗切斯特流行病学项目的一个实例。
Mayo Clin Proc. 2012 Feb;87(2):151-60. doi: 10.1016/j.mayocp.2011.11.009.